RTT News | FDA Rejects Novartis Heart Failure Drug RTT News The FDA has rejected a new drug from Norvartis designed to prevent heart failure. The drug, called RLX030, has shown promise up through Stage II testing, but thus far the FDA believes that more data is needed before the drug can hit the market. The ... |
